Profitelligence Profitelligence · Filing Ledger Open PFE research →

Form 8-K · Current Report · Filed 2024-05-22

Pfizer Announces Multi-Year Cost Reduction Program

Pfizer Inc. announced a multi-year program to reduce its cost of goods sold, expected to deliver savings of approximately $1.5 billion by the end of 2027. The program will involve operational efficiencies, network structure changes, and product portfolio enhancements, with one-time costs of about $1.7 billion, primarily for severance and implementation costs, to be recorded in 2024.

Filer
Pfizer Inc. PFE · NYSE
Filed
Accession
0000078003-24-000113
CIK
0000078003
Signal
High impactHealthcare

Items reported

Item 2.05

Costs Associated with Exit or Disposal Activities

Mass Layoff Restructuring Costs Severance Payout

Market reaction

Close before filing

$28.56

Next session

+0.5%

Since filing

-12.4%

Latest close

$25.01

What happened, not what will happen — closing prices around the filing date.

About Pfizer Inc.

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.

Exchange NYSE Industry Drug Manufacturers - General Company website ↗

Never miss another PFE filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts